Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy.

Toshiaki Iwase Evan N Cohen Hui Gao Angela Alexander Megumi Kai Vivian Chiv Xiaoping Wang Savitri Krishnamurthy Diane D Liu Yu Shen Kumiko Kida Alexandre Reuben Rachel M Layman David L Ramirez Debasish Tripathy Stacy L Moulder Clinton Yam Vicente Valero Bora Lim James M Reuben Naoto Tada Ueno

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)

Pembrolizumab monotherapy achieved durable treatment responses. Patients with a high baseline T-cell clonality had prolonged disease control with pembrolizumab.

Keyphrases

advanced non small cell lung cancer
combination therapy
locally advanced
clinical trial
stem cells
radiation therapy
rectal cancer